Herkens Lea, Droste Patrick, Boor Peter
Institute of Pathology, Uniklinik RWTH, Aachen, Germany.
Division of Nephrology and Clinical Immunology, Uniklinik RWTH, Aachen, Germany.
Am J Physiol Cell Physiol. 2025 Jul 1;329(1):C119-C135. doi: 10.1152/ajpcell.00198.2025. Epub 2025 May 30.
The macrophage migration inhibitory factor (MIF) family consists of the structurally homologous proteins MIF, D-dopachrome tautomerase (D-DT), and D-DT like (D-DTL). Although MIF is the most well-described member, much less is known about D-DT, and very little about D-DTL. Here, we provide an overview of the structure, similarities, and biological functions of these proteins. MIF and D-DT can have both protective and aggravating effects on various diseases depending on the disease type, involved organ, cell type, and disease stage. Given that the pathological consequence of many chronic diseases is fibrosis, we here discuss the role of these proteins in organ fibrosis, particularly of the kidney, liver, heart, lung, and skin. We discuss the various roles of these proteins, suggesting that MIF might have pro- and antifibrotic roles in different organs. To date, D-DT has been shown to have only antifibrotic roles. We tackle potential translational considerations and propose future research avenues to better understand the involvement of MIF family in organ fibrosis.
巨噬细胞移动抑制因子(MIF)家族由结构同源蛋白MIF、D - 多巴色素互变异构酶(D - DT)和D - DT样蛋白(D - DTL)组成。尽管MIF是描述最为详尽的成员,但关于D - DT的了解要少得多,而关于D - DTL的了解则微乎其微。在此,我们概述这些蛋白的结构、相似性及生物学功能。根据疾病类型、受累器官、细胞类型及疾病阶段,MIF和D - DT对多种疾病既可能具有保护作用,也可能具有加重作用。鉴于许多慢性疾病的病理后果是纤维化,我们在此讨论这些蛋白在器官纤维化,尤其是肾脏、肝脏、心脏、肺和皮肤纤维化中的作用。我们探讨这些蛋白的多种作用,提示MIF在不同器官中可能具有促纤维化和抗纤维化作用。迄今为止,已表明D - DT仅具有抗纤维化作用。我们探讨潜在的转化研究考量因素,并提出未来的研究途径,以更好地理解MIF家族在器官纤维化中的作用。